Asian Journal of Research and Reports in Urology

Epidemiological Insights into Bladder Pain Syndrome among Bangladeshi Women: Prevalence, Clinical Presentations, Management Preferences, and Associated Risk Factors

Md. Rubel Ali

Department of Public Health, First Capital University of Bangladesh, Chuadanga, 7200, Bangladesh.

Sharmin Akter

Central Medical College, Cumilla, 3500, Bangladesh.

Sazin Islam *

Department of Public Health, First Capital University of Bangladesh, Chuadanga, 7200, Bangladesh.

Sumon Mallick

Department of Public Health, First Capital University of Bangladesh, Chuadanga, 7200, Bangladesh.

*Author to whom correspondence should be addressed.

---

Abstract

Background: Bladder Pain Syndrome (BPS) is a complex condition with varying clinical presentations and management strategies. Despite its global prevalence, there is limited research addressing the syndrome in Bangladeshi women. This study aimed to bridge this knowledge gap, providing insights into the prevalence, clinical characteristics, and management strategies of BPS within this demographic.

Methods: A sample of 1984 Bangladeshi women was analyzed using a cross-sectional study design. Through stratified random sampling, participants were assessed for BPS symptoms, management preferences, and associated risk factors. Statistical analyses included descriptive statistics and chi-square tests for determining associations.

Results: The prevalence of BPS was found to be 16.2% among the sampled population. The primary clinical features identified were pelvic pain (91.3%), frequent urination (83.2%), and nocturia (75.2%). Oral medications emerged as the predominant management strategy (63.9%). Significant associations were found between BPS and previous urinary tract infections, with a 2.5-fold increased risk. Moreover, fibromyalgia was identified as a notable comorbidity in 16.8% of BPS patients.

Conclusion: BPS presents a significant health concern for Bangladeshi women, with specific clinical manifestations and management preferences. The associations between BPS, prior UTIs, and fibromyalgia necessitate a multi-pronged clinical approach for effective diagnosis and management. This study underscores the urgency of enhanced awareness and tailored interventions for BPS within the Bangladeshi context.

Keywords: Bladder pain syndrome, prevalence, clinical characteristics, management strategies, Bangladeshi women

---

---

---

References

Hanno PM, Burks DA, Clemens JQ, Dmochowski RR, Erickson D, Fitzgerald MP, Lai HH. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. The Journal of Urology. 2011;185 (6):2162-2170.

Berry SH, Elliott MN, Suttorp M, Bogart LM, Stoto MA, Eggers P, Clemens JQ. Prevalence of symptoms of bladder pain syndrome/ interstitial cystitis among adult females in the United States. The Journal of Urology. 2011;186(2):540-544.

Lee CL, Kuo HC. Pathophysiology of bladder pain syndrome and interstitial cystitis: a perspective from studies using animal models. Tzu Chi Medical Journal. 2011;23(3) :82-87.

Warren JW, Van De Merwe JP, Nickel JC. Interstitial cystitis/bladder pain syndrome and nonbladder syndromes: facts and hypotheses. Urology. 2011;78(4):727-732.

Davis NF, Brady CM, Creagh T. Interstitial cystitis/painful bladder syndrome: epidemiology, pathophysiology and evidence-based treatment options. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2017; 213:30-37.

Hossain MZ, Rahman M, Ahmed HU. Chronic pelvic pain among Bangladeshi women: a neglected issue. International Journal of Reproductive Medicine;2019.

Rahman H, Zaman TU. Health-seeking behavior of Bangladeshi women: an empirical study in Rajshahi District. Bangladesh Journal of Medical Science. 2017;16(4):557-564.

Ahmed T, Rana MA, Sultana M. Prevalence of chronic pain and high-impact chronic pain in cancer survivors in the United States. Journal of Bangladesh Medical Research Council. 2020;45(2);89-95.

Suskind AM, Berry SH, Ewing BA, Elliott MN, Suttorp MJ, Clemens JQ. The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: results of the RAND Interstitial Cystitis Epidemiology male study. The Journal of Urology. 2013;189 (1):141-145.

Peters KM, Killinger KA, Mounayer MH. Are ulcerative and nonulcerative interstitial cystitis/painful bladder syndrome 2 distinct diseases? A study of coexisting conditions. Urology. 2013;82(2):402-407.

Chiu B, Tai HC, Chung SD, Birder LA. Botulinum toxin a for bladder pain syndrome/interstitial cystitis. Toxins. 2013;5 (7):1201-1216.

Liu HT, Kuo HC. A prospective study comparing tender point count with potassium sensitivity test as a diagnostic marker for bladder pain syndrome/interstitial cystitis. Neurourology and Urodynamics. 2012;31(8): 1187-1192.

Chung MK, Chung RR, Gordon D. Botulinum neurotoxin treatment of pelvic pain syndromes: broadening the scope. Toxins. 2012;10(1):16-28.

Osborne JL, Heidelbaugh JJ, Zoorob RJ. Diagnosis and management of chronic bladder pain. American family physician. 2016;94(10):807-815.

Clemens JQ, Brown SO, Calhoun EA. Mental health diagnoses in patients with interstitial cystitis/painful bladder syndrome and chronic prostatitis/chronic pelvic pain syndrome: a case/control study. The Journal of Urology. 2013;190(4):1378-1383.

Kairys AE, Schmidt-Wilcke T, Puiu T. Increased brain gray matter in the primary somatosensory cortex is associated with increased pain and mood disturbance in patients with interstitial cystitis/painful bladder syndrome. The Journal of Urology. 2015;193(1):131-137.